首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3479篇
  免费   250篇
  国内免费   33篇
耳鼻咽喉   17篇
儿科学   86篇
妇产科学   76篇
基础医学   348篇
口腔科学   148篇
临床医学   267篇
内科学   808篇
皮肤病学   62篇
神经病学   196篇
特种医学   210篇
外科学   691篇
综合类   36篇
一般理论   1篇
预防医学   203篇
眼科学   105篇
药学   195篇
中国医学   1篇
肿瘤学   312篇
  2023年   26篇
  2022年   18篇
  2021年   82篇
  2020年   55篇
  2019年   74篇
  2018年   103篇
  2017年   71篇
  2016年   59篇
  2015年   89篇
  2014年   119篇
  2013年   133篇
  2012年   209篇
  2011年   230篇
  2010年   118篇
  2009年   134篇
  2008年   200篇
  2007年   195篇
  2006年   194篇
  2005年   181篇
  2004年   159篇
  2003年   166篇
  2002年   152篇
  2001年   68篇
  2000年   72篇
  1999年   51篇
  1998年   38篇
  1997年   30篇
  1996年   31篇
  1995年   26篇
  1994年   42篇
  1993年   17篇
  1992年   64篇
  1991年   53篇
  1990年   47篇
  1989年   43篇
  1988年   27篇
  1987年   22篇
  1986年   37篇
  1985年   28篇
  1984年   32篇
  1983年   34篇
  1982年   17篇
  1979年   19篇
  1978年   15篇
  1977年   18篇
  1976年   12篇
  1974年   19篇
  1973年   11篇
  1968年   12篇
  1967年   14篇
排序方式: 共有3762条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.

Background

Pazopanib has been approved for first-line treatment of patients with metastatic renal-cell carcinoma on the basis of clinical trials that enrolled only patients with adequate renal function. Few data are available on the safety and efficacy of pazopanib in patients with renal insufficiency. This study investigated the effect of kidney function on treatment outcomes in such patients.

Patients and Methods

We retrospectively analyzed data of metastatic renal-cell carcinoma patients treated with pazopanib from January 2010 to June 2016 with respect to renal function. Patients with Modification of Diet in Renal Disease ≤ 60 mL/min/1.73 m2 (group A) were compared to patients with Modification of Diet in Renal Disease > 60 mL/min/1.73 m2 (group B) in terms of progression-free survival, toxicities, response rates, and overall survival.

Results

A total of 229 patients were included: 128 in group A and 101 in group B. Median progression-free survival was 14 months (95% confidence interval [CI], 9.4-18.5) and 17 months (95% CI, 11.4-22.8), and overall survival was 30.5 months (95% CI, 8-53) and 41.4 months (95% CI, 21-62) for group A and group B, respectively, with no significant difference (P = .6). No significant difference between the 2 groups was reported in the incidence of adverse events. Dose reductions were more frequent in group A patients (66% vs. 36%; P = .04).

Conclusion

Although the dose of pazopanib was reduced more frequently in patients with renal impairment, kidney function at therapy initiation does not adversely affect the safety and efficacy of pazopanib.  相似文献   
6.
7.
8.
9.
The novel coronavirus SARS‐CoV‐2 has emerged as one of the most compelling and concerning public health challenges of our time. To address the myriad issues generated by this pandemic, an interdisciplinary breadth of research, clinical and public health communities has rapidly engaged to collectively find answers and solutions. One area of active inquiry is understanding the mode(s) of SARS‐CoV‐2 transmission. Although respiratory droplets are a known mechanism of transmission, other mechanisms are likely. Of particular importance to global health is the possibility of vertical transmission from infected mothers to infants through breastfeeding or consumption of human milk. However, there is limited published literature related to vertical transmission of any human coronaviruses (including SARS‐CoV‐2) via human milk and/or breastfeeding. Results of the literature search reported here (finalized on 17 April 2020) revealed a single study providing some evidence of vertical transmission of human coronavirus 229E; a single study evaluating presence of SARS‐CoV in human milk (it was negative); and no published data on MERS‐CoV and human milk. We identified 13 studies reporting human milk tested for SARS‐CoV‐2; one study (a non‐peer‐reviewed preprint) detected the virus in one milk sample, and another study detected SARS‐CoV‐2 specific IgG in milk. Importantly, none of the studies on coronaviruses and human milk report validation of their collection and analytical methods for use in human milk. These reports are evaluated here, and their implications related to the possibility of vertical transmission of coronaviruses (in particular, SARS‐CoV‐2) during breastfeeding are discussed.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号